NeuroMetrix Announces Quell Dispensing Partnership with Comprehensive Pain Specialists
September 08 2016 - 7:00AM
Business Wire
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that
Comprehensive Pain Specialists will offer Quell® Wearable Pain
Relief Technology™ in selected clinic locations.
“We are pleased that a growing number of forward-thinking pain
management providers are integrating the Quell technology into
their treatment protocols,” said Shai N.Gozani, M.D., Ph.D.,
President and CEO of NeuroMetrix. “We know that patients look to
their healthcare providers for information on the newest pain
relief options and value recommendations at the point-of-service
from our provider partners.”
“We are always looking for innovative pain relief technologies
to offer patients as part of an individualized treatment plan,”
said Peter Kroll, M.D., Medical Director of Comprehensive Pain
Specialists. “We are excited to offer Quell technology to our
patients as part of a multidisciplinary approach to pain
management.”
About Comprehensive Pain Specialists
Comprehensive Pain Specialists, formed in 2005, is a group of
experienced physicians and staff dedicated to identifying and
treating chronic pain. With 60+ locations in 12 states across the
country, CPS combines evolving, precision diagnostics and
innovative therapies to assist each patient with their chronic pain
management needs. For more information, please visit
www.cpspain.com.
About Quell
Quell is designed for millions of people suffering from chronic
pain. The advanced wearable device is lightweight and can be worn
during the day while active, and at night while sleeping. It has
been cleared by the FDA for treatment of chronic pain without a
prescription. In a recent study, 81% of Quell users reported an
improvement in their chronic pain. Quell users can start, stop, and
adjust therapy discreetly via the optional Quell Relief app. Quell
also offers advanced sleep tracking that provides feedback on eight
dimensions of sleep including sleep duration, quality, body
position, time out of bed, and repetitive leg movements throughout
the night. Quell was the winner of the 2016 SXSW (South by
Southwest) Innovation Award for Best Wearable Technology. Quell is
available at select healthcare professionals and retailers. To find
a Quell retailer near you, visit the Store Locator at
QuellRelief.com.
About NeuroMetrix
NeuroMetrix is a commercial stage, innovation driven
healthcare company combining bioelectrical and digital medicine to
address chronic health conditions including chronic pain, sleep
disorders, and diabetes. The company’s lead product is Quell, an
over-the-counter wearable therapeutic device for chronic pain.
Quell is integrated into a digital health platform that helps
patients optimize their therapy and decrease the impact of chronic
pain on their quality of life. The company also markets DPNCheck®,
a rapid point-of-care test for diabetic neuropathy, which is the
most common long-term complication of Type 2 diabetes. The company
maintains an active research effort and has several pipeline
programs, including a therapeutic device for restless leg syndrome.
The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health
Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160908005152/en/
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024